A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2001
11/14/2001	EP0722322B1 Compounds, compositions and treatment of allergies and inflammation therewith
11/14/2001	EP0713527B1 Fungicidal methods and compositions for killing yeast and sporular microorganisms
11/14/2001	EP0688360B1 Bone stimulating factor
11/14/2001	EP0652948B1 Development of a vector to target gene expression to the epidermis of transgenic animals
11/14/2001	CN1322246A Restin and methods of use thereof
11/14/2001	CN1322214A Induction of antiobiotic proteins and peptides by LAIT/sCD14-protein
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1322143A Gene therapy for cerebrovasclar disorders
11/14/2001	CN1322136A Neuroimmunophilins for selective neuronal radioprotection
11/14/2001	CN1322134A Naphthalenecarboxamides as tachykinin receptor antagonists
11/14/2001	CN1322130A Inhibitors of type 3 3a -hydrosteroid dehydrogenase
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321638A Method for preparing methylsulfonate trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperid-1-yl)-1-propanol
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321511A Preparation method of medicated liquor for curing traumatic injury
11/14/2001	CN1321486A Yinkang lotion
11/14/2001	CN1074766C Alkylaminobenzothiazole and -benzoxazole derivatives
11/14/2001	CN1074677C Medicine for treating apoplexy and its preparing process
11/14/2001	CN1074666C Folic acid supplementing agent for preventing neural tube deformity
11/14/2001	CN1074665C Method and medical agent for diagnosis and/or therapy of arthritis
11/13/2001	US6316692 Insertion of nucleotide sequences into genomes; inject sample into testes, recover preferential polypeptide from transformed cells
11/13/2001	US6316638 Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
11/13/2001	US6316617 For treating physiological disorders associated with an excess of neuropeptide y, such as feeding disorders and certain cardiovascular diseases, medical diagnosis
11/13/2001	US6316597 Protein for use in treatment of bone or cartilage defects
11/13/2001	US6316502 Administering disulfide derivative of dithiocarbamate compound to bind to iron
11/13/2001	US6316485 1,5-diphenylpyrazole derivatives
11/13/2001	US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316474 Treatment of pain, schizophrenia, parkinson's disease, stroke and depression
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316471 Treating inflammatory or autoimmune diseases
11/13/2001	US6316466 Pyrazole derivatives P-38 MAP kinase inhibitors
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316462 Methods of inducing cancer cell death and tumor regression
11/13/2001	US6316460 Containing a heptenoic acid derivative and a tribasic phosphate salt as a stabilizer; hmg-coa reductase inhibitor
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
11/13/2001	US6316444 SRC kinase inhibitor compounds
11/13/2001	US6316438 Fused pyridopyridazine inhibitors of cGMP phosphodiesterase
11/13/2001	US6316418 Regulated apoptosis
11/13/2001	US6316415 Sulfonamide interleukin-1β converting enzyme inhibitors
11/13/2001	US6316413 Peptide agonists of bradykinin B2 receptor
11/13/2001	US6316259 Antisense inhibition of glycogen synthase kinase 3 alpha expression
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6316199 Arginase II
11/13/2001	US6316197 Monitoring exposure poisons; obtain mammalian body fluid, detect gene expression pattern, comparing pattern to control, evaluate if sample has been exposed to poisons
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001	CA2161869C N-alkylthio polyamine derivatives as radioprotective agents
11/08/2001	WO2001083782A2 Novel proteases
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083748A1 Novel g protein-coupled receptor protein and dna thereof
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083711A2 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
11/08/2001	WO2001083710A2 Clearance of neoplastic cells from mixed cellular compositions using viruses
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083558A1 Agonists/antagonists of the gpr56 receptor as appetite control agents
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083529A2 Immunoadhesin for the prevention of rhinovirus infection
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083522A2 Growth factor modified protein matrices for tissue engineering
11/08/2001	WO2001083513A2 Antisense modulation of inhibitor of dna binding-1 expression
11/08/2001	WO2001083512A1 3-nitrogen-6,7-dioxygen steroids and uses related thereto
11/08/2001	WO2001083508A1 Antisense modulation of zinc finger protein-217 expression
11/08/2001	WO2001083497A1 Cyclipostins, a method for their production and the use of the same
11/08/2001	WO2001083496A1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
11/08/2001	WO2001083486A1 Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
11/08/2001	WO2001083481A1 Imidazopyridine derivatives
11/08/2001	WO2001083478A2 Hydantoin-containing glucokinase activators
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083470A1 Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
11/08/2001	WO2001083469A1 Cdk inhibitors having 3-hydroxychromen-4-one structure
11/08/2001	WO2001083465A2 Alkynyl phenyl heteroaromatic glucokinase activators
11/08/2001	WO2001083461A1 Thiazole and oxazole derivatives
11/08/2001	WO2001083456A1 Condensed heteroaryl derivatives
11/08/2001	WO2001083454A1 Benzosuberonylpiperidine compounds as analgesics
11/08/2001	WO2001083450A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
11/08/2001	WO2001083449A2 Rigid pyrrolidone modulators of pkc
11/08/2001	WO2001083445A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor
11/08/2001	WO2001083439A2 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
11/08/2001	WO2001083438A2 New gamma selective retinoids
11/08/2001	WO2001083434A2 P-(sulfonyl)-aryl and heteroaryls amines
11/08/2001	WO2001083431A1 Mmp-12 inhibitors
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001083385A2 Devices and method for production of traceable immunizing drinking water, other liquids and gas
11/08/2001	WO2001082975A2 Membrane-permeant peptide complexes for medical imaging
11/08/2001	WO2001082966A1 Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
11/08/2001	WO2001082965A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	WO2001082940A1 Plant extract of the olea europaea species as no-synthase inhibitor and uses
11/08/2001	WO2001082939A1 Treatment of conditions of the central nervous system using mycobacteria

1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 1564